title: Ventricular assist devices (VAD) therapy: new technology, new hope?
abstract: Ventricular assist devices are commonly utilized in the treatment of end-stage heart failure. Advances in continuous flow technology have improved efficiency, size, implantability, extended support, and overall patient outcomes. This has led to an expanded role of left ventricular assist device (LVAD) clinical use and applications. This review describes the advances and current state of LVAD devices and provides a future outlook for this technology.
authors.affiliation: Methodist DeBakey Heart & Vascular Center, The Methodist Hospital, Houston, Texas, USA.
authors.forename: Limael E
authors.initials: LE
authors.lastname: Rodriguez
authors.forename: Erik E
authors.initials: EE
authors.lastname: Suarez
authors.forename: Matthias
authors.initials: M
authors.lastname: Loebe
authors.forename: Brian A
authors.initials: BA
authors.lastname: Bruckner
mesh_terms: D000818:Animals; D006333:Heart Failure / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006353:Heart-Assist Devices / Q000009:adverse effects; D006801:Humans; D011474:Prosthesis Design; D020127:Recovery of Function; D016896:Treatment Outcome; D016277:Ventricular Function, Left
keywords: INTERMACS; bridge to transplant; mechanical assist device; ventricular assist device